Â鶹´«Ã½Ó³»­

Â鶹´«Ã½Ó³»­

Explore the latest content from across our publications
Join The Â鶹´«Ã½Ó³»­

Log In

Forgot Password?
Create New Account

Loading... please wait

2017 Annual Meeting | C153 - Alzheimer's Dementia: Diagnosis and Treatment

Wednesday 04/26/17
07:00 AM - 09:00 AM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Seminar
David S. Knopman, MD, FÂ鶹´«Ã½Ó³»­
Participants should be able to describe the continuum of cognitive function in the Alzheimer spectrum; understand the major and minor genetic influences on AD, describe the evolving biomarker diagnostic process for defining AD as a pathophysiology, and describe the appropriate indications for cholinesterase inhibitors and memantine.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge
Trainee, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider
Didactic
Event Timeline
07:00 AM - 07:30 AM Speaker The Clinical Diagnosis of MCI and Dementia Due to AD
Richard J. Caselli, MD, FÂ鶹´«Ã½Ó³»­
07:30 AM - 07:40 AM Speaker Controversies in Nosology of MCI and Dementia: What’s New?
David S. Knopman, MD, FÂ鶹´«Ã½Ó³»­
07:40 AM - 08:05 AM Speaker Biomarkers for the Diagnosis of AD
David S. Knopman, MD, FÂ鶹´«Ã½Ó³»­
08:05 AM - 08:30 AM Speaker The Role for Genetics in AD Diagnosis and Management
Richard J. Caselli, MD, FÂ鶹´«Ã½Ó³»­
08:30 AM - 08:50 AM Speaker Therapeutics in AD for 2017 and the Near Term
David S. Knopman, MD, FÂ鶹´«Ã½Ó³»­
08:50 AM - 09:00 AM Q&A Questions and Answers
Faculty Disclosures
Richard J. Caselli, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Caselli has received research support from NIA. The institution of Dr. Caselli has received research support from State of Arizona.
David S. Knopman, MD, FÂ鶹´«Ã½Ó³»­ Dr. Knopman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DIAN TU study. The institution of Dr. Knopman has received research support from NIH.